Your trusted source for investing success

Tag: department of justice

Valens GroWorks Appoints President

Valens GroWorks Appoints President

Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“)  is pleased to announce that Mr. Saul Katz has joined the Company as its President.

Mr. Katz brings to Valens 35 years of entrepreneurship, senior management experience and scientific expertise in functional food product development and commercialization. Over his career he established research collaborations with leading

Wi2Wi Announces Board Changes

Wi2Wi Corporation (TSXV:YTY), announces that Mr. Daniel Phelan has resigned as a director and Chairman of the Board of Directors. Mr. Michael R. Sonnenreich and Fraser C. Henderson Sr., M.D have joined the Board of Directors and Mr. Sonnenreich was elected as the Chairman of the Board of Directors.

As quoted

Cannabix Technologies Provides Update on Marijuana Breathalyzer Development

Cannabix Technologies Inc.(CSE: BLO, OTC PINK: BLOZF) (the “Company”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to provide a development update on its FAIMS Beta 2.0 (field asymmetric waveform ion mobility spectrometry) based marijuana breathalyzer for the detection of ∆9-tetrahydrocannabinol (“THC”) in human

Aegerion Pharmaceuticals, a Subsidiary of Novelion Therapeutics, Enters into Agreement in Principle to Settle Class Action Shareholder Lawsuit

Novelion Therapeutics, a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today announced that on December 3, 2016, Aegerion Pharmaceuticals, an indirect, wholly-owned subsidiary of Novelion, entered into an agreement in principle to settle all claims in the class action shareholder lawsuit pending

Frank Holmes Sees Peak Gold in 2017

Frank Holmes Sees Peak Gold in 2017

Mining Journal’s Best Americas Based Fund Manager tells us about the four-year gold cycle, the current correction phase, the Trump impact on the economy and where gold will be in 2017.

Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation

HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology
company with fully integrated commercial and drug development operations
with a primary focus in Hematology and Oncology, today announced that it
has settled its ANDA patent litigation relating to FOLOTYN. As a result
of the settlement with the last remaining ANDA filer, Fresenius Kabi
USA, LLC, and

Identillect Technologies Corp. and Accessible Compliance Announce Partnership

Identillect Technologies Corp. (TSXV:ID) and Accessible Compliance have announced a new partnership in the United States. Their reseller partnership provides Identillect with access to hundreds of commercial businesses searching for a solution to remain compliant with state, federal and industry data handling regulations.

According to the press release:
Accessible Compliance is in the process of

Aegerion Pharmaceuticals Announces Preliminary Agreements in Principle With DOJ and SEC Related to Ongoing Investigations

CAMBRIDGE, Mass., May 12, 2016 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (“Aegerion” or the “Company”) (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that it has reached preliminary agreements in principle with the Department of Justice (

Gold Outlook 2017!

Click here to get a clear perspective on the gold price and what the experts see coming in 2017 with our FREE Special Report (value of $49). Limited time offer. No credit card required.   Get My Free Report  
Enter Your Log In Credentials

Privacy & Legal Policy

Privacy Policy

Investing News Network